# Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

> **NCT05301660** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sir Run Run Shaw Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Nicotine transdermal patch

## Key facts

- **NCT ID:** NCT05301660
- **Lead sponsor:** Sir Run Run Shaw Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-22
- **Primary completion:** 2023-02-15
- **Final completion:** 2023-02-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05301660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05301660, "Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05301660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*